These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38322083)

  • 1. Variability of Multiple Sclerosis Walking Scale and Multiple Sclerosis Impact Scale Scores in People Without Multiple Sclerosis.
    Binshalan T; Buckley E; Nair S; Mcneill A
    Cureus; 2024 Jan; 16(1):e51811. PubMed ID: 38322083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties of the Croatian version of the Multiple Sclerosis Walking Scale (MSWS-12).
    Jerković A; Nikolić Ivanišević M; Šimić N; Poljičanin A; Đogaš Z; Rogić Vidaković M
    Disabil Rehabil; 2023 Oct; 45(20):3373-3378. PubMed ID: 36222552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of smoking cessation on multiple sclerosis disease progression.
    Rodgers J; Friede T; Vonberg FW; Constantinescu CS; Coles A; Chataway J; Duddy M; Emsley H; Ford H; Fisniku L; Galea I; Harrower T; Hobart J; Huseyin H; Kipps CM; Marta M; McDonnell GV; McLean B; Pearson OR; Rog D; Schmierer K; Sharrack B; Straukiene A; Wilson HC; Ford DV; Middleton RM; Nicholas R
    Brain; 2022 May; 145(4):1368-1378. PubMed ID: 34623418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of prolonged-release fampridine
    Hupperts R; Gasperini C; Lycke J; Ziemssen T; Feys P; Xiao S; Acosta C; Koster T; Hobart J
    Ther Adv Neurol Disord; 2022; 15():17562864221090398. PubMed ID: 35601756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scales.
    Tang CC; Soh SE; Boonstra F; Noffs G; Kolbe SC; Butzkueven H; Evans A; Van der Walt A
    Mult Scler Relat Disord; 2022 Feb; 58():103495. PubMed ID: 35085981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.
    Motl RW; Plummer P; Backus D; Hebert JR; Neal WN; Ng A; Lowman J; Bethoux F; Schmidt H; McBurney R; McCully KK; Cutter G
    Mult Scler Relat Disord; 2024 Aug; 88():105715. PubMed ID: 38889558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder.
    Kim W; Park EY; Hyun JW; Huh SY; Park NY; Jang H; Kim SH; Kim HJ
    J Clin Neurol; 2020 Apr; 16(2):270-276. PubMed ID: 32319244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.
    Dadvar A; Jameie M; Azizmohammad Looha M; Parsaei M; Zeynali Bujani M; Amanollahi M; Babaei M; Khosravi A; Amirifard H
    PLoS One; 2024; 19(2):e0297235. PubMed ID: 38349929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
    Chorschew A; Kesgin F; Bellmann-Strobl J; Flachenecker P; Schiffmann I; Rosenthal F; Althoff P; Drebinger D; Arsenova R; Rasche L; Dorsch EM; Heesen C; Paul F; Stellmann JP; Schmitz-Hübsch T
    Health Qual Life Outcomes; 2023 Oct; 21(1):110. PubMed ID: 37814258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of Persian 12-Item multiple sclerosis walking scale: a replication study.
    Naghdi S; Ansari NN; Haghparast A; Nakhostin-Ansari A; Khalifeloo M; Biglar M; Lotfi R; Hasson S
    BMC Res Notes; 2023 Apr; 16(1):45. PubMed ID: 37016445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness and clinically meaningful changes for the Persian versions of the multiple sclerosis walking scale-12 and the modified fatigue impact scale following balance and gait rehabilitation in people with multiple sclerosis.
    Monjezi S; Molhemi F; Shaterzadeh Yazdi MJ; Salehi R; Mehravar M; Kashipazha D
    Physiother Theory Pract; 2022 Mar; 38(3):464-470. PubMed ID: 32431220
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study.
    Kalron A; Ehling R; Baert I; Smedal T; Rasova K; Heric-Mansrud A; Elorriage I; Nedeljkovic U; Tachino A; Gargul L; Gusowski K; Cattaneo D; Borgers S; Hebert J; Dalgas U; Feys P
    Mult Scler Relat Disord; 2020 Nov; 46():102511. PubMed ID: 32949848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29.
    Gasperini C; Hupperts R; Lycke J; Short C; McNeill M; Zhong J; Mehta LR
    J Neurol Sci; 2016 Nov; 370():123-131. PubMed ID: 27772740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine.
    Hobart J; Ziemssen T; Feys P; Linnebank M; Goodman AD; Farrell R; Hupperts R; Blight AR; Englishby V; McNeill M; Chang I; Lima G; Elkins J;
    CNS Drugs; 2019 Jan; 33(1):61-79. PubMed ID: 30535670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an individual 12-week community-located "start-to-run" program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis.
    Feys P; Moumdjian L; Van Halewyck F; Wens I; Eijnde BO; Van Wijmeersch B; Popescu V; Van Asch P
    Mult Scler; 2019 Jan; 25(1):92-103. PubMed ID: 29113572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales.
    Sonder JM; Bosma LV; van der Linden FA; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Feb; 18(2):196-201. PubMed ID: 21908479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fear of falling, not falls, impacts leisure-time physical activity in people with multiple sclerosis.
    Kalron A; Aloni R; Givon U; Menascu S
    Gait Posture; 2018 Sep; 65():33-38. PubMed ID: 30558943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study.
    Baert I; Freeman J; Smedal T; Dalgas U; Romberg A; Kalron A; Conyers H; Elorriaga I; Gebara B; Gumse J; Heric A; Jensen E; Jones K; Knuts K; Maertens de Noordhout B; Martic A; Normann B; Eijnde BO; Rasova K; Santoyo Medina C; Truyens V; Wens I; Feys P
    Neurorehabil Neural Repair; 2014 Sep; 28(7):621-31. PubMed ID: 24503204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29.
    Raffel J; Wallace A; Gveric D; Reynolds R; Friede T; Nicholas R
    PLoS Med; 2017 Jul; 14(7):e1002346. PubMed ID: 28692670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.